Experimental study of Ingavirin ® antiviral activity against human adenovirus

Antibiotiki i Khimioterapiya

Volumn 55, Issue 9-10, 2010, Pages 19-24

  Zarubaev, V V ^a   Slita, A V ^a   Sirotkin, A K ^a   Nebolsin, V E ^a   Kiselev, O I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Antiviral activity; Electron microscopy; Hep 2 cell culture; Human type 5 adenovirus; Ingavirin

Indexed keywords

AMIDE; ANTIVIRUS AGENT; DICARBOXYLIC ACID; IMIDAZOLE DERIVATIVE; PENTANEDIOIC ACID IMIDAZOLYL ETHANAMIDE;

ARTICLE; CELL NUCLEUS; CELL STRAIN HEPG2; DOSE RESPONSE; DRUG EFFECT; ELECTRON MICROSCOPY; HUMAN; HUMAN ADENOVIRUS; PATHOGENICITY; PHYSIOLOGY; ULTRASTRUCTURE; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; AMIDES; ANTIVIRAL AGENTS; CELL NUCLEUS; DICARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; IMIDAZOLES; MICROSCOPY, ELECTRON; VIRULENCE; VIRUS REPLICATION;

EID: 79954532736     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Das A., Trousdale M. D., Ren S., Lien E. J. Inhibition of Herpes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiffbases of amino-hydroxyguanidine tosylate. Antiviral Res 1999;44:3:201-208. (Pubitemid 30017947)
2. De Clercq E., Sakuma T., Baba M. et al. Antiviral activity of phospho-nylmethoxyalkyl derivatives of purines and pyrimidines. Antiviral Res 1987;8:5-6:261-272. (Pubitemid 18073222)
3. Arav-Boger R., Echavarria M., Forman M. et al. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J 2000;19:11:1097-1100.
4. Shetty A. K., Gans H. A., So S. et al Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol 2000;29:1:69-73. (Pubitemid 30036679)
5. Gavin P. J., Katz B. Z. Intravenous Ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 2002;110:1 pt 1:1-8.
6. Bordigoni P., Carret A. S., Venard V. et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001;32:9:1290-1297. (Pubitemid 32405900)
7. La Rosa A. M., Champlin R. E., Mirza M. et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001;32:6:871-876. (Pubitemid 32524820)
8. Trousdale M. D., Goldschmidt P. L., Nobrega R. Evaluation of ganciclovir against human adenovirus type 5 infection in cell culture and cotton rat eyes. Antiviral Res 1993;20:Suppl. 1:48.
9. Chen F. E., Liang R. H., Lo J. Y. et al. Treatment of adenovirus-associ-ated haemorrhagic cystitis with ganciclovir. Bone Marrow Transplant 1997;20:11:997-999. (Pubitemid 27510966)
10. Hillenkamp J., Reinhard T., Ross R. S. et al. The effect of cidofovir 1% with and without cyclosporin A 1 % as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophtalmology 2002;109:5:845-850. (Pubitemid 34465214)
11. Hoffman J. A., Shah A. J., Ross L. A., Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001;7:7:388-394. (Pubitemid 32799057)
12. Romanowski E G., Yates K. A., Gordon Y. J. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Antiviral Res 2001;52:3:275-280. (Pubitemid 33000117)
13. Romanowski E. G., Gordon Y. J., Araullo-Cruz T. et al. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand white rabbit ocular model. Invest Ophtalmol Vis Sci 2001;42:8:1812-1815. (Pubitemid 32652357)
14. Safrin S., Chenington J., Joffe H. S. Cidofovir. Review of current and potential clinical uses. Adv Exp Med Biol 1999;458:111-120.
15. Hitchcock M. J. M., Jaffe H. S., Martin J. C, Stagg R. J. Cidofovir, a new agent with potent anti-herpesvirus activity. Antivir Chem Chemother 1996;7:3:115-127. (Pubitemid 26150100)
16. Ogrdon Y. J., Naesens L., De Clercq E. et al. The treatment of adenoviral conjunctivitis with topical cidofovir. Cornea. 1996;15:5:546. (Pubitemid 26271797)
17. Coca S., Perazella M. A. Rapid communication: acute renal failure associated with tenofovin evidence of drug-induced nephrotoxicity. Am J Med Sci 2002;324:6:342-344. (Pubitemid 36109329)
18. Kaneko H, Kato K., Mori S., Shigeta S. Antiviral activity of NMS03 against adenovirus in vitro. Antiviral Res 2001;52:3:281-288. (Pubitemid 33000118)
19. Zarubaev V. V., SlitaA. V., Krivitskaya V. Z. et al. Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 In vitro. Antiviral Res 2003;58:2:131-137. (Pubitemid 36556216)
20. Rautenschlein S., Miller R. L., Sharma J. M. The inhibitory effect of the imidazoquinolinamine S-28828 on the pathogenesis of a type II adenovirus in turkeys. Antiviral Res 2000;46:3:195-205. (Pubitemid 30365187)
21. Naesens L., Lenaerts L., Andrei G. et al. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother 2005;49:1010-1016. (Pubitemid 40327717)
22. Mentel R., Kinder M., Wegner U. et al. Inhibitory activity of 3-fluoro-2-deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antiviral Res 1997;34:3:113-119. (Pubitemid 27220187)
23. Zarubaev V. V., SlitaA. V., Sukhinin V. P. et al. Effect of 6-azacytidine on the course of experimental adenoviral infection in newborn Syrian hamsters. J Chemother 2007;19:1:44-51.
24. Alexeeva I., Dyachenko N., Nosach L. et al. 6-Azacytidine - compound with wide spectrum of antiviral activity. Nucleosides Nucleotides Nucleic Acids. 2001;20:4-7:1147-1152. (Pubitemid 32821943)
25. Weber J. M., Ruzindana-Umunyana A., Imbeault L., Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res 2003;58:2:167-173. (Pubitemid 36556219)
26. Zhang Y., Schneider R. J. Adenovirus inhibition of cellular protein synthesis and the specific translation of late viral mRNAs. Semin Virol 1993;4:229-236.
27. Xing L., Tikoo S. K. Packaging of viral RNAs in virions of adenoviruses. Virol J 2009;5:6:16.
28. Erturk E., Ostapchuk P., Wells S. I. et al. Binding of CCAAT displacement protein CDP to adenovirus packaging sequences. J Virol 2003;77:11:6255-6264. (Pubitemid 36588396)
29. Ostapchuk P., Hearing P. Regulation of adenovirus packaging. Curr Top Microbiol Immunol. 2003;272:165-185. (Pubitemid 36458328)